(Reuters) – The U.S. Food and Drug Administration on Monday cleared a new version of Abbott Laboratories’ continuous glucose monitoring device, helping the company build upon the success of its fastest-growing diabetes product. FreeStyle Libre 2, which was app... More »
(Reuters Health) – Obese women who have weight-loss surgery between pregnancies may be less likely to experience complications like high blood pressure and preterm births in their second pregnancy, a recent study suggests. Researchers examined hospital records... More »
(Reuters Health) – People with type 1 diabetes may be more than twice as likely to develop potentially fatal complications when they use cannabis somewhat regularly than when they avoid the drug or rarely indulge, a study suggests. Researchers surveyed 932 adu... More »
(Reuters Health) – Severely injured patients are more likely to have complications or die if they have a cluster of cardiovascular risk factors like high blood pressure, diabetes and obesity, a recent study suggests. This collection of health problems, called ... More »
(Reuters Health) – No one can say if it’s the walks or the unconditional love, but there’s something about owning a dog that goes hand in hand with better heart health, suggests a study in eastern Europe. Researchers examined more than 1,700 adults in the Czec... More »
(Reuters Health) – The likelihood that U.S. patients with renal failure will get a kidney transplant is lower for those who get dialysis at for-profit dialysis centers, a new study shows. In examining the records of more than a million dialysis patients, resea... More »
(Reuters) – The U.S. Food and Drug Administration has approved Xeris Pharmaceuticals Inc’s glucagon therapy that aims to treat severely low sugar levels in diabetes patients, the drugmaker said on Tuesday. The condition, called hypoglycemia, can cause acute co... More »
(Reuters Health) – Pregnant women at high risk for developing gestational diabetes may be less likely to experience this complication when they switch to a Mediterranean diet instead of sticking with their usual eating habits, a recent experiment suggests. Res... More »
(Reuters Health) – Older adults with slightly elevated blood sugar, sometimes called “prediabetes,” usually don’t develop full-blown diabetes, a Swedish study suggests. Researchers followed 2,575 men and women aged 60 and older without diabetes for up to 12 ye... More »
Family background can matter for the health of diabetic children, according to researchers in Denmark who found young patients’ blood sugar control was linked with the level of education their mothers had attained. “One of the first explanations that comes to ... More »
(Reuters Health) – Children and young adults with chronic conditions like asthma, diabetes, and ADHD may be more likely to develop mental illness than youth who don’t have physical health problems, a U.S. study suggests. Researchers followed more than 48,000 y... More »
(Reuters Health) – In people at high risk for type 1 diabetes, 14 days of therapy with the experimental drug teplizumab delayed development of the disease by a year or more, according to results from a mid-stage study presented Sunday. The 76 study participant... More »
(Reuters) – Insulin-dependent patients with type 2 diabetes saw a significant drop in their blood sugar levels after wearing Abbott Laboratories Inc’s continuous glucose monitoring system for three months compared with those who use routine fingerstick testing... More »
(Reuters Health) – If you’re talking vitamin D and expecting it to lower your risk of getting type 2 diabetes when you get older, it’s time to lower your expectations. A new study, the largest of its kind, has found that taking 4000 international units (IU) pe... More »
(Reuters) – British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement to insulin in adults with a rare type of the disease. Forxiga can now be used along with insulin in patients w... More »
(Reuters) – The U.S. Food and Drug Administration declined to approve a drug developed by Sanofi SA and Lexicon Pharmaceuticals Inc intended for use with insulin in patients with type 1 diabetes, the companies said on Friday. The decision comes about two month... More »
(Reuters Health – In a small pilot study that screened 45 Ohio middle school students for cardiovascular risk factors, a third of the children had abnormal levels of cholesterol or blood sugar, and two kids were found to have undiagnosed diabetes. Guidelines r... More »
(Reuters Health) – Three in four obese people with diabetes who had a common type of weight-loss operation called Roux-en-Y gastric bypass (RYGB) experienced remission of their diabetes within a year after surgery, a Danish study found. Five years later, 27 pe... More »
(Reuters Health) – Kids living with type 1 diabetes are no different from their peers in their reading and math test scores, a Danish study suggests. The less common form of diabetes, known as type 1, develops in childhood or young adulthood when the pancreas ... More »
(Reuters Health) – Diabetic patients who take statins to treat high cholesterol may get an added benefit: a lower risk of damage to the retina, a new study suggests. Researchers found that diabetic patients taking statins were 14 percent less likely to develop... More »
(Reuters Health) – When young boys gain a lot of weight at puberty, they may be increasing their risk of developing diabetes decades later, a Swedish study suggests. Researchers examined body mass index (BMI) measurements for 36,176 men when they were 8 years ... More »
(Reuters Health) – Air pollution could be responsible for 3.2 million new cases of type 2 diabetes every year globally, suggests a new analysis. “We estimate that about 14 percent of diabetes in the world occurs because of higher levels of air pollution, that’... More »
(Reuters) – Eli Lilly & Co said on Monday that its drug Jardiance, along with insulin therapy, met the main goal of two trials testing it in patients with type 1 diabetes. Jardiance, although not approved for type-1 diabetes, is approved for use in adults with... More »
(Reuters Health) – People with diabetes may have healthier blood sugar levels when they get lots of encouragement from family and friends to help them overcome the stress of managing their disease, a U.S. study suggests. Researchers surveyed 308 veterans with ... More »
(Reuters Health) – People who eat lots of processed and red meat are at increased risk of developing chronic liver disease and insulin resistance, a diabetes risk factor – especially if they like their steak well done, an Israeli study suggests. Researchers fo... More »
(Reuters Health) – People living in the U.S. but born elsewhere may have lower risk for heart disease and stroke than their native-born neighbors, suggests a new study. Foreign-born residents had a range of risks, however. Women from Europe and men from Africa... More »
COPENHAGEN (Reuters) – Danish drugmaker Novo Nordisk came closer to winning European approval for diabetes drug Ozempic, its biggest growth prospect, when a European Medicines Agency (EMA) experts’ panel issued a positive recommendation on Friday. The once-wee... More »
The number of people living with diabetes has tripled since 2000, pushing the global cost of the disease to $850 billion a year, medical experts said on Tuesday. More »
Novo Nordisk said on Friday the U.S. Food and Drug Administration (FDA) approved an expanded use of its diabetes drug to reduce the risk of cardiovascular events such as heart attack and stroke. More »
By Lisa Rapaport(Reuters Health) – Hailing from the so-called stroke belt, a band of southern U.S. states with high stroke mortality rates, is associ More »
By Will Boggs MD(Reuters Health) – An eight-week mindfulness-based stress reduction (MBSR) program not only reduces stress, but could also lower bloo More »
By Lisa Rapaport(Reuters Health) – A shift in how donor kidneys are allocated in the U.S. has been linked with higher transplant rates for black and More »
By Carolyn Crist(Reuters Health) – Middle aged adults who do even a small amount of regular strength training exercise may be lowering their risk of More »
An Illinois judge on Friday halted implementation of a measure that would have made Chicago the latest U.S. city to tax sweetened drinks, saying a lawsuit filed by retailers to block it must run its course. More »
By Will Boggs MD(Reuters Health) – Meeting some or all of the American Heart Association’s seven ideal cardiovascular health goals is associated with More »
By Shereen Lehman(Reuters Health) – If a parent or sibling has cirrhosis due to non-alcoholic fatty liver disease, a person’s odds of having liver sc More »
By Shereen Lehman(Reuters Health) – – Death rates from liver cancer in the U.S. have doubled since the 1980s and continue to rise, largely due to ris More »
By Andrew M. SeamanHeart health in the U.S. has generally improved since the start of the 21st century, but not for adults living in poverty, a new More »
Seattle’s City Council voted on Monday to levy a special tax on sodas and other sugary beverages sold to consumers, becoming the latest of several local government bodies across the country to take such action for the sake of public health. More »
By Lisa RapaportAn experimental foot-temperature monitoring system might one day be able to detect when diabetic patients are developing foot ulcers, More »
A general view shows a power plant under construction on the suburbs of Sevastopol, Crimea, February 9, 2017. Picture taken February 9, 2017. REUTERS/Anton Zverev Russia’s $1.3 billion plan to build two new power plants in Crimea aimed to show that Moscow coul... More »
By Anne Harding(Reuters Health) – A next step in wearable health sensors might be a device that causes a patch of skin to sweat, then analyzes the pe More »
FILE PHOTO – Commuters cycle past a bus queue outside Waterloo Station in London, Britain August 6, 2015. REUTERS/Dylan Martinez/File Photo People who cycle to work have a substantially lower risk of developing cancer or heart disease or dying prematurely, and... More »
By Ronnie Cohen(Reuters Health) – The nation’s first soda tax is fulfilling health experts’ goals in Berkeley, California.Sales of sugar-swee More »
By Gene Emery(Reuters Health) – – For overweight people with heart disease, trying and failing to lose weight may be more dangerous than not losing w More »
A diabetic applies an Insulin pen injection in Vienna November 13, 2012. REUTERS/Heinz-Peter Bader By Lisa Rapaport(Reuters Health) – – Adults with type 1 diabetes may be able to manage their blood sugar levels just as well with multiple daily insu More »
By Shereen Lehman(Reuters Health) – Young men who are overweight or obese have up to double the risk of normal-weight peers for developing liver dise More »
By Carolyn CristEven without high blood pressure or other signs of illness, obese adults have a much higher risk of developing heart disease than nor More »
A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease, according to data released on Sunday from a so-called real world study sponsored by AstraZeneca. More »
By Andrew M. Seaman(Reuters Health) – Support programs for new mothers help them to breastfeed their babies for longer periods and to keep breast mi More »
By Ronnie Cohen(Reuters Health) – Up to one-fourth of adults in sub-Saharan Africa suffer from chronic kidney disease and only a small fraction ever More »
By Madeline Kennedy(Reuters Health) – Women who got their first period at age 11 or earlier are at higher risk of developing diabetes during pregnanc More »
By Rob Goodier(Reuters Health) – Exercise may be an efficient way for obese pregnant women to lower their risk of diabetes, dangerously high blood pr More »
By Will Boggs MD(Reuters Health) – A genetic trait that affects red blood cells and is fairly common among African Americans and Hispanic Americans c More »
Novo Nordisk, the world’s top maker of diabetes drugs, is investing 115 million pounds ($145 million) in a new research center in Britain, undeterred by Brexit. More »
FILE PHOTO – Young men sing outside Victoria station in London during the Christmas party season, December 17, 2015. REUTERS/Paul Hackett/File Photo Scientists have found that the brain cells in mice that stimulate the urge to eat can be activated by alcohol a... More »
French multinational pharmaceutical company SANOFI logo is seen at the headquarters in Paris, France, March 8, 2016. REUTERS/Philippe Wojazer/File Photo France’s Sanofi has filed a lawsuit in the United States accusing Novo Nordisk of falsely claiming that San... More »
A screen displays trading information for stocks- Pfizer, Abbott Laboratories, Merck and Company and Eli Lilly and Company on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., May 16, 2016. REUTERS/Brendan McDermid/File Photo Two leading ... More »
A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed U.S regulators said on Friday they would allow Eli Lilly and Co to state that its diabetes drug Jardiance reduces risk of death... More »
By Lisa Rapaport(Reuters Health) – Adults who sleep no more than five hours a night are more likely to be heavy soda drinkers than people who get mor More »
By Lisa Rapaport(Reuters Health) – Traditional treadmill tests used to estimate heart disease risk might not provide accurate results for women, a re More »
By Lisa Rapaport(Reuters Health) – People with type 1 diabetes often develop other autoimmune disorders, such as thyroid and gastrointestinal disease More »
By Madeline Kennedy(Reuters Health) – Health might be its own reward, but even cash incentives only work in the short term to motivate people to exer More »
By Kathryn Doyle(Reuters Health) – Obstructive sleep apnea is linked with an increased risk of developing type 2 diabetes, new research shows. More »
By Lisa Rapaport(Reuters Health) – The number of U.S. diabetics with healthy blood sugar levels has declined in recent years, a study suggests. More »
By Carolyn Crist(Reuters Health) – Children who order a combination meal at fast-food restaurants are more likely to get a sugary drink that ups the More »
The World Health Organization said on Tuesday governments should raise taxes on sugary drinks to fight what it says are global obesity and diabetes epidemics. More »
A logo is seen in front of the entrance at the headquarters French drugmaker Sanofi in Paris October 30, 2014. REUTERS/Christian Hartmann/File Photo French drugmaker Sanofi and Google owner Alphabet’s life sciences firm Verily are to invest about $500 million ... More »
By Madeline Kennedy (Story refiles from August 3rd instance to add new paragraph 5) By Madeline Kennedy More »
LONDON GlaxoSmithKline and Google parent Alphabet’s life sciences unit are creating a new company focused on fighting diseases by targeting electrical signals in the body, jump-starting a novel field of medicine called bioelectronics. Verily Life Sciences – kn... More »
LONDON Roche has no plans to sell its diabetes testing business, despite a pummeling in the past three years from U.S. price cuts, and the Swiss drugmaker expects the unit to return to sales growth in 2017. Roland Diggelmann, head of Roche diagnostics, said th... More »
Reuters Health – After one year, gastric bypass surgery did a better job of bringing type 2 diabetes into remission than an intensive diet and exercise regimen, according to results of a small trial among obese patients. Gastric bypass surgery precipitates wei... More »
SHANGHAI China, already a global powerhouse in high-tech areas from solar panels to bullet trains, is turning its industrial might to the challenge of making more of its own drugs for a vast and aging population. Given the 10 years or more it typically takes t... More »
LONDON Three of Europe’s top drugmakers – GlaxoSmithKline, Roche and Sanofi – face health checks this week at high-profile presentations designed to show they can overcome looming market threats. The unusual confluence of investor days comes at a testing time ... More »
(Reuters Health) – Some doctors and midwives may underestimate the risk for postpartum diabetes among women who develop a version of the disease during pregnancy, a small British study suggests. Researchers focused on the risk of what’s known as type 2 diabete... More »
COPENHAGEN Shares in Novo Nordisk (NOVOb.CO) rose as much as 5 percent on Monday after the U.S. Food and Drug Administration (FDA) approved the diabetes drug Tresiba, allowing the Danish drugmaker to prepare its largest ever drug launch. The FDA’s decision lat... More »
PARIS French drugmaker Sanofi said the European Commission had cleared its key cholesterol drug Praluent for the treatment of so-called “bad cholesterol,” or low-density lipoprotein (LDL) cholesterol, in certain adult patients with hypercholesterolemia. The dr... More »
PARIS Sanofi said on Monday a second late-stage Phase III study of its LixiLan diabetes drug had met its main target, readying it for regulatory submissions by the fourth quarter in the United States and the first quarter of next year in the European Union. Li... More »
(Reuters Health) – Weight-loss surgery beats medication for controlling type 2 diabetes in obese people, according to the longest-term trial ever to compare the two approaches. Half of the patients treated with weight-loss surgery in the study were diabetes-fr... More »
WILLIAMSON, WV With coal trains chugging past in the distance, Jack Perry watches as his wife, Margie, plants row upon row of Hungarian pepper seedlings in the community garden that residents of this West Virginia coal town call the “Garden of Eatin’.” “Th... More »
LONDON Governments around the world should increase taxes on cigarettes and other tobacco products to save lives and generate funds for stronger health services, the World Health Organization (WHO) said on Tuesday. In a report entitled “The Global Tobacco Epid... More »
